PM-WCPV-SFP0-1

PepMix™ SARS-CoV-2 (Spike Fusion-Peptide)

US$572.00

In stock

Description

About PepMix™ SARS-CoV-2 (Spike Fusion-Peptide)

Pool of 28 peptides derived from a peptide scan (truncational scan (peptide length 11 to 17aa)) through Spike glycoprotein - Fusion peptide AA814-830 (Swiss-Prot ID: P0DTC2: 814 - 830) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-Related Coronavirus 2).

PepMix™ SARS-CoV-2 (Spike Fusion-Peptide) - Specifications

Amount: 25 µg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells)
Purity: Research Plus Grade: each peptide is guaranteed to be main product (HPLC/MS)
(equivalent to an average purity of 70%)
Delivery Format: Freeze-dried in glass vial
Application(s): T-cell Immunity
Condition(s)/Topic(s): Covid-19, Infection, Respiratory infection
Standard Delivery Time: 2-5 days

Background: A 15 amino acid stretch of the SARS-CoV-2 spike glycoprotein was recently shown to induce strong T-cell reactivity in individuals following SARS-CoV-2 vaccination and infection, and responses were also found in individuals with prior exposure to other human coronaviruses (Loyal et al., Science 2021). The amino acid stretch (named iCope) was independently predicted as a region of major antigenic potential in silico (Ong et al. Comp. Struct. Biotechnol. J. 2021).

The respective peptide sequence is located in the spike glycopeptide fusion domain and is likely to give rise to one or more universal immunodominant coronavirus-specific peptide epitopes across a range of presenting HLA-alleles.

Our PepMix peptide pool spans the region from SARS-CoV-2 Spike aa814 to aa830 including all possible 17-, 16-, 15-, 14, 13-, 12- and 11-amino acid peptides in order to maximize T cell stimulation.

Are you interested in your own custom PepMix? Choose your sequence, amount, purity and pool format. We will assist you along the way. Custom PepMix Peptide Pools.

PepMix™ Peptide Pools
Protein-spanning mixtures of overlapping peptides (PepMix™) are extremely efficient for
- Antigen-specific T cell stimulation in T cell assays (e.g. in ELISpot, ICS, cell-mediated cytotoxicity or proliferation assays)
- In-vitro T cell expansion
- Dendritic cell pulsing
- Immune monitoring
- Cellular immune response profiling
- T cell epitope identification
- Standardization of T cell assays

Benefits of PepMix™
- Production ISO 9001 certified
- Each peptide quality controlled and guaranteed for identity and purity
- CoA and HPLC-MS data available
- High batch-to-batch consistency
- No false positive T cell responses by contaminating deletion peptides
- No toxic inhibition of T cell responses due to stringent purification of each peptide
- Minimization of endotoxin contamination due to low bioburden process
- ADCF policy in place
- HLA independent stimulation (with antigen spanning peptide pools)

References

References for PepMix™ SARS-CoV-2 (Spike Fusion-Peptide)

References
Read References with
PepMix™ Peptide Pools for Infectious Diseases
COVID-19 related PepMixes™
PepMix™ Control Pools

Application Notes
Peptide Tools to Support the Fight against COVID-19
Alem et al (2020) Full text
Developing Multi-HIV Antigen Specific T-Cells as a Component of a Cure Strategy
Lam et al. (2015) Full text
Peptide-stimulated Expansion of Virus-specific T cells For Preventative Treatment After Allogeneic Stem Cell Transplantation
Gary et al. (2015) Full text

Testimonials
"To establish a novel role for myeloid derived suppressor cells (Pallett et al, Nat. Med. 2015) in chronic viral infection, we utilised the PepMix CEF Pool (extended) as well as a custom synthesized PepMix spanning the core region of HBV genotype D . Whereas, the CEF peptide pool consists of 32 peptides, each corresponding to a defined HLA class I-restricted T-cell epitope from Cytomegalo, Epstein-Barr, and Influenza virus, the latter custom PepMix included 15meric peptides overlapping by 10 amino acids. Specifically this composition enabled us to monitor both the antiviral CD8+ and CD4+ T cell responses in chronic HBV infection and the non-antigen specific T cells that are known to mediate immunopathology in the liver. Our entire experience with JPT, from ordering/delivery to use in the lab was excellent. Not only were the reagents able to perform reliably and consistently in vitro from batch to batch, the customer and technical support provided was continually available and efficient when needed. JPT will remain our go-to company for purchasing peptides."
Dr. Laura J Pallett, Infection and Immunity, University College London, UK

Documentation

Documentation for PepMix™ SARS-CoV-2 (Spike Fusion-Peptide)

Properties

Properties of PepMix™ SARS-CoV-2 (Spike Fusion-Peptide)

Properties Values
Amount: 25 µg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells)
Application: T-cell immunity
Category: PepMix Peptide Pools, PepMix Peptide Pools Infections
Condition / Topic: Covid-19, Infection, Respiratory infection
Layout: Freeze-dried in glass vial
Organism: SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Purity: Research Plus Grade: each peptide is guaranteed to be main product (HPLC/MS)
Quantification: Yes

Further Information to PepMix™ SARS-CoV-2 (Spike Fusion-Peptide)

Information Values
Sequence: KRSFIEDLLFNKVTLAD
Loading...
TÜV Rheinland certified
Health - made in Germany
Quality Assurance

All production is ISO 9001:2015 certified.

Check our list of products, click and go.

Get a quote